首頁 › 急性淋巴母細胞性白血病 › 哥倫比亞特區 › Washington
Washington, DC 的 急性淋巴母細胞性白血病 臨床試驗
16 項針對 急性淋巴母細胞性白血病 的研究正在 Washington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
招募中
- Children's National Medical Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 距離 7 英里
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
招募中2 期
- Children's National Hospital, Washington D.C.
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Children's National Medical Center, Washington D.C.
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 距離 7 英里
- Nih/Nhlbi, Bethesda · 距離 7 英里
Massage Impact on Sleep in Pediatric Oncology
招募中
- Children's National Hospital, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Feasibility/Acceptability of Attentional-Control Training in Survivors
招募中
- Children's National Hospital, Washington D.C.
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
招募中
- Children's National Hospital, Washington D.C.
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · 距離 7 英里
其他城市的 急性淋巴母細胞性白血病 試驗
- Houston, TX28 項研究
- New York City, NY23 項研究
- Baldwin Park, CA21 項研究
- Seattle, WA21 項研究
- Chicago, IL20 項研究
- Atlanta, GA19 項研究
- Memphis, TN16 項研究
- Philadelphia, PA16 項研究
- Boston, MA15 項研究
- Los Angeles, CA14 項研究
- Mountain View, CA13 項研究
- Durham, NC13 項研究
Washington 的其他研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌55 項研究
- 乳癌46 項研究
- 轉移性癌症43 項研究
- 肺癌41 項研究
- 前列腺癌38 項研究
- 肥胖症33 項研究
- 大腸直腸癌29 項研究
- 心血管疾病28 項研究
- 膀胱癌26 項研究
- 急性髓系白血病24 項研究
- 卵巢癌23 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。